Research use only. Read more

Metabolic / GLP-1

AOD-9604

A fragment of the C-terminus of human GH researched for stimulating lipolysis without affecting blood glucose or IGF-1.

Quick facts

Molecular weight

1,816 Da

Half-life

0.5 h

Frequency

daily

Admins / wk

7

Routes

SubQ

Typical dose

300 mcg–500 mcg

Mechanism & positioning

A fragment of the C-terminus of human GH researched for stimulating lipolysis without affecting blood glucose or IGF-1.

Researched for: lipolysis modulation, fat oxidation.

Reconstitution defaults

Default vial

2 mg

BAC water

2 mL

Concentration

1000 mcg/mL

Doses per vial

~6

Other stocked vial sizes: 5 mg.

Calculate with this peptide

References

  • Heffernan M et al., Endocrinol, 2001.

Related peptides in the Metabolic / GLP-1 class

Frequently asked questions about AOD-9604

What is the typical research dose range for AOD-9604?
AOD-9604 is most commonly investigated at 300 mcg–500 mcg per administration, daily. These values reflect documented research-stage protocols and are not medical recommendations.
What is the half-life of AOD-9604?
AOD-9604 has an approximate plasma half-life of 0.5 hours. Practical steady state is reached after roughly five half-lives — about 0 days under continuous administration.
How is AOD-9604 administered in research protocols?
Published research uses subq administration. Typical reconstitution is 2 mg vial in 2 mL of bacteriostatic water, producing a concentration of 1000 mcg/mL.
What vial sizes are commonly available for AOD-9604?
Common stocked vial sizes are 2 mg, 5 mg. The 2 mg vial is the most-used default in published protocols.